According to the Zhitong Finance App, Shanghai Pharmaceutical (02607.HK) announced that on June 6, 2025, the company received a notification letter from the controlling shareholder Shangshi Group: From May 1, 2025 to June 6, 2025, Shangshi Group increased its total H share holdings by 38 million through its wholly-owned subsidiary Shangshi International.

Zhitongcaijing · 06/10 09:41
According to the Zhitong Finance App, Shanghai Pharmaceutical (02607.HK) announced that on June 6, 2025, the company received a notification letter from the controlling shareholder Shangshi Group: From May 1, 2025 to June 6, 2025, Shangshi Group increased its total H share holdings by 38 million through its wholly-owned subsidiary Shangshi International.